Nav: Home

New guidelines for treatment and management of COPD exacerbations

March 15, 2017

A multi-disciplinary task force of chronic obstructive pulmonary disease (COPD) experts has published comprehensive new guidelines on the treatment of COPD exacerbations, providing new advice on the treatment of exacerbations in outpatients and the initiation of pulmonary rehabilitation during or after an exacerbation of COPD, among other topics.

The European Respiratory Society (ERS) and American Thoracic Society (ATS) collaborated to develop the new guidelines, published today (16 March 2017) in the European Respiratory Journal. Chronic obstructive pulmonary disease (COPD) is a long-term condition that causes inflammation in the lungs, damaged lung tissue and a narrowing of the airways, making breathing difficult. The World Health Organization (WHO) predicts that COPD will become the third leading cause of death worldwide by 2030.

Previous guidelines have relied on evidence gathered mostly from patients hospitalised with severe exacerbations but the new document covers antibiotic and corticosteroid therapy for outpatients who experience mild and moderate exacerbations. The recommendations for outpatient care also include starting pulmonary rehabilitation 3 weeks after discharge from hospital following a severe exacerbation.

In addition, the paper provides recommendations related to non-invasive ventilation treatment and home-based management, and is centred on six key questions:
  • Oral corticosteroids versus. no corticosteroids for non-hospitalised patients
  • Oral corticosteroids vs. intravenous corticosteroids for hospitalised patients
  • Antibiotics vs. no antibiotics for ambulatory patients
  • Non-invasive mechanical ventilation vs. usual care for hospitalised patients
  • Home-based management vs. hospitalisation
  • Pulmonary rehabilitation vs. usual care for hospitalised patients
Professor Jadwiga Wedzicha, lead author of the guideline and editor-in-chief of the American Journal of Respiratory and Critical Care Medicine, commented: "Our guideline provides new recommendations based on more solid evidence for established therapies and including populations of patients that were not significantly represented in previous guidelines. The recommendations cover the different kinds of drugs and therapies that can be used at home and in a hospital setting, answering new questions for healthcare professionals."

Dr Marc Miravitlles, the ERS Guidelines Director and co-author of the new guideline, commented: "This new guideline can help improve the management of exacerbations in patients with COPD. The recommendations include new advice for general practitioners as they refer to ambulatory patients who may experience mild or moderate exacerbations. In addition, we provide new evidence to effective strategies, such as pulmonary rehabilitation, which has been shown to improve the outcomes of exacerbated COPD patients."

The evidence used to shape each debate was subject to comprehensive analysis using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.

Each question is broken down in to sub-sections to detail a summary of the evidence, benefits, harms, further considerations, conclusions and research needs, wider expert opinions, ERS/ATS recommendation, remarks, and values and preferences.

The authors of the task force state that more detailed studies should be carried out in several of the areas discussed in the paper, to enable a more comprehensive set of guidelines be produced. They also state that recommendations should be reconsidered when new evidence becomes available.
-end-
Title: Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society (ERS/ATS) guideline

European Lung Foundation

Related Copd Articles:

COPD appears to cause more severe symptoms in women
Women who develop COPD report smoking fewer cigarettes than men; and yet, women experience greater breathing impairments, are subjected to more acute exacerbations of symptoms and report lower quality of life than men with the disease, according to research presented at ATS 2019.
African-Americans with COPD appear less likely to use pulmonary rehab
African-American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby.
COPD and type 2 diabetes
COPD and type 2 diabetes are two highly prevalent global health conditions associated with high mortality and morbidity.
Number of nonsmokers with COPD on the rise
The global burden of COPD is high, and prevalence of nonsmokers with COPD has been increasing.
Flu vaccination keeps COPD patients out of the hospital
A new study published in the January issue of CHEST® establishes that patients with chronic obstructive pulmonary disease (COPD) face heightened risks of death, critical illness, and hospitalization if they develop the flu and demonstrates the beneficial effects of influenza vaccination.
More Copd News and Copd Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...